Billiontoone vs Twist Bioscience
Twist Bioscience is the larger business, with $377m of revenue in fiscal 2025 against $305m for Billiontoone (1.2 times as much). Billiontoone grew faster (100.0% against 20.3%). Billiontoone kept more of each dollar of sales as profit: a net margin of 2.4% against -20.6%. Twist Bioscience carries less debt relative to equity (0.0% against 11.9%).
| Latest fiscal year | BilliontooneBLLN, 2025 | Twist BioscienceTWST, 2025 |
|---|---|---|
| Revenue | $305m | $377m |
| Revenue growth | 100.0% | 20.3% |
| Net income | $7.5m | −$77.7m |
| Operating margin | 5.3% | -36.2% |
| Net margin | 2.4% | -20.6% |
| Return on equity | 6.5% | -16.4% |
| Free cash flow | $15.7m | −$75.6m |
| Cash | $496m | $183m |
| Total debt | $57.2m | $0 |
| Debt to equity | 11.9% | 0.0% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | $0 | — |
| Employees | 713 | 979 |
| Market value | $6.03bn | $8.74bn |
| Price vs our value range | — | — |
| Moat score | — | 11 (Weak) |
| Insider trades, 12 months | 11 buys, 169 sales | 0 buys, 180 sales |